Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016
04 Jul 2016 - 06 Jul 2016

Rac1 Levels Linked to Mechanics of Invadopodia Formation and Metastasis

By BiotechDaily International staff writers
Posted on 09 Jun 2014
Print article
Image: Electron micrograph shows a cancer cell (upper darker area) that has formed three invadopodia that are penetrating the adjacent extracellular matrix (lower lighter area) (Photo courtesy of Yeshiva University).
Image: Electron micrograph shows a cancer cell (upper darker area) that has formed three invadopodia that are penetrating the adjacent extracellular matrix (lower lighter area) (Photo courtesy of Yeshiva University).
Cancer researchers have linked increases and decreases in the level of Rac1 protein to the appearance and disappearance of invadopodia, amoeboid-like protrusions used by metastatic cancer cells to invade neighboring tissues.

Invadopodia release enzymes that degrade the extracellular matrix (ECM) and allow cellular movement while propelling the cancer cell into neighboring tissues.

Rac1, also known as Ras-related C3 botulinum toxin substrate 1, is a protein encoded by the RAC1 gene. This gene can produce a variety of alternatively spliced versions of the Rac1 protein, which appear to carry out different functions. Rac1 is thought to play a significant role in the development of various cancers, including melanoma and non-small-cell lung cancer. As a result, it is now considered a therapeutic target for these diseases. Rac1 is a small (approximately 21 kDa) signaling G-protein (more specifically a GTPase), and is a regulator of many cellular processes, including the cell cycle, cell-cell adhesion, motility (through the actin network), and of epithelial differentiation (proposed to be necessary for maintaining epidermal stem cells).

To study Rac1 involvement in invadopodia dynamics, investigators at Yeshiva University (New York, NY, USA) developed a genetically encoded, single-chain Rac1 fluorescence resonance energy (FRET) transfer biosensor technique that, combined with live-cell imaging, revealed exactly when and where Rac1 was activated inside cancer cells.

Results obtained by this methodology revealed that low levels of Rac1 were found during formation of invadopodia and while they were actively degrading the ECM. Elevated Rac1 levels coincided with disappearance of the invadopodia. These findings were confirmed by using siRNAs to silence the RAC1 gene. When the gene was inactivated, ECM degradation increased. Conversely, when Rac1 activity was enhanced - using light to activate a Rac1 protein analog - the invadopodia disappeared.

“We have known for some time that invadopodia are driven by protein filaments called actin,” said senior author Dr. Louis Hodgson, assistant professor of anatomy and structural biology at Yeshiva University. “But exactly what was regulating the actin in invadopodia was not clear. Rac1 levels in invadopodia of invasive tumor cells appear to surge and ebb at precisely timed intervals in order to maximize the cells’ invasive capabilities. So high levels of Rac1 induce the disappearance of ECM-degrading invadopodia, while low levels allow them to stay—which is the complete opposite of what Rac1 was thought to be doing in invadopodia.”

“Rac1 inhibitors have been developed,” said Dr. Hodgson, “but it would not be safe to use them indiscriminately. Rac1 is an important molecule in healthy cells, including immune cells. So we would need to find a way to shut off this signaling pathway specifically in cancer cells.”

Related Links:

Yeshiva University



Print article

Channels

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel

Huge Modifiable Biomedical Database to Be Available on the Wikidata Site

Genome researchers are exploiting the power of the open Internet community Wikipedia database to create a comprehensive resource for geneticists, molecular biologists, and other interested life scientists. While efficiency in generating scientific data improves almost daily, applying meaningful relationships between... Read more

Business

view channel

Bio-Innovation Agreement to Strengthen Ties between Canada and Israel

A recently signed agreement aims at encouraging academic and entrepreneurial ties in the field of bio-innovation between a Canadian and an Israeli university. The agreement will establish a strong relationship between the University of Toronto (Canada) – in the form of the Institute of Biomaterials and Biomedical Engineering... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.